GENE THERAPIES: HOW WILL INDICATION-BASED PRICING AFFECT PATIENT ACCESS AND COST-CONTAINMENT MECHANISMS FOR PAYERS?

被引：0

|

作者：

Grosvenor, A. ^{[1
]}

Ermacora, P. ^{[1
]}

机构：

[1] Precis Xtract, London, England

来源：

VALUE IN HEALTH | 2019年 / 22卷

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PBI19

引用

收藏

页码：S420 / S420

页数：1

相关论文

共 2 条

[1] A rare disease patient/caregiver perspective on fair pricing and access to gene-based therapies
White W.
[J]. Gene Therapy, 2020, 27 (10-11) : 474 - 481
[2] ASSESSING THE EVOLUTION OF THE PRICING AND ACCESS LANDSCAPE FOR CELL AND GENE THERAPIES IN THE US AND EU3 THROUGH A WEB-BASED PORTAL TO ENGAGE PAYERS
Singh, Kumar K.
Clapton, G. S.
Graham, A.
Ignjatovic, T.
Jones-Phillips, D.
[J]. VALUE IN HEALTH, 2019, 22 : S490 - S491